Global Lumasiran Market, By Drug Class(Miscellaneous Metabolic Agents, Others), Application (Primary Hyperoxaluria, Others), Dosage form (Injection, Solution), Route of Administration (Subcutaneous), Demographic (Adult, Pediatric), End-Users (Clinics, Hospitals, Diagnostic center, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Lumasiran Market
Global lumasiran market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.30% in the above mentioned forecast period.
Lumasiran, also known as Oxlumo is a HAO1-directed small interfering ribonucleic acid (siRNA). It is used to treat primary hyperoxaluria type1 (PH1) by lowering urinary oxalate levels in pediatric and adult patients. Primary hyperoxaluria type1 is a rare genetic metabolic disorder in which level of oxalate increases in the urine and further results in the kidney failure or kidney stones.
Rise in the prevalence of primary hyperoxaluria, inevitable inheritance of the disease, advancement of therapies for treatment of rare diseases, and increase in the awareness towards genetic diseases coupled with genetic counselling are the factors that will expand the global lumasiran market.
Rise in research and development activities and ongoing clinical trials are expected to provide beneficial opportunities for the global lumasiran market in the forecast period of 2021-2028.
Lumasiran shows side effects such as abdominal pain, breathing difficulties, and injection site reaction (redness, swelling, pain, and itching). These side effects and lack of medical publications are the factors that will restraint the market growth. High cost of medication, focus of developing therapies on the novel approaches to treat the rare diseases and storage condition are the factors that will challenge the global lumasiran market in the forecast period mentioned above.
This lumasiran market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global lumasiran market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Lumasiran Market Scope and Market Size
The lumasiran market is segmented on the basis of drug class, application, dosage form, route of administration, demographic, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the lumasiran market is segmented into miscellaneous metabolic agents and others.
- On the basis of application, the lumasiran market is segmented into primary hyperoxaluria and others.
- On the basis of dosage form, the lumasiran market is segmented into injection and solution.
- On the basis of route of administration, the lumasiran market is segmented into subcutaneous.
- On the basis of demographic, the lumasiran market is segmented into adult and pediatric.
- On the basis of end-users, the lumasiran market is segmented into clinics, hospitals, diagnostic center, and others.
- The lumasiran market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Global Lumasiran Market Country Level Analysis
Global lumasiran market is analyzed, and market size information is provided by the country, drug class, application, dosage form, route of administration, demographic, end-users, and distribution channel as referenced above.
The countries covered in the global lumasiran market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the lumasiran market due to the existence of major key players, high prevalence rate, well-developed healthcare sector and increase in the government support for research & development in this region. Global lumasiran market in the Asia-Pacific is expected to grow during the forecast period because of growing focus of pharmaceutical companies on advancement of therapies for treatment of rare diseases, increasing social awareness, growing government support and rising healthcare expenditure.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global lumasiran market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Lumasiran Market Share Analysis
Global lumasiran market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global lumasiran market.
The major player covered in the global lumasiran market report is Alnylam Pharmaceuticals, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.